Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Doctors, advocates and patients press committee for cautious psilocybin access measures
Summary
Psychiatry groups, patients and advocacy organizations testified in favor of narrowly tailored bills to expand access to psilocybin for therapeutic uses and to dismiss simple‑possession charges under specified safety conditions; opponents warned of public‑health risks.
The Joint Committee considered several proposals concerning psilocybin possession, therapeutic access and tasking a study of equitable access. Speakers included psychiatrists and medical researchers who urged a limited, cautious approach. Dr. Jelam Biswas of the Massachusetts Psychiatric Society said the society supports narrowly tailored bills that allow dismissal of simple possession if safety criteria are met (age 21+,…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
